104 related articles for article (PubMed ID: 6111404)
1. CSF and plasma somatostatin levels in acromegaly.
Wass JA; Penman E; Medbak S; Rees LH; Besser GM
Clin Endocrinol (Oxf); 1980 Sep; 13(3):235-41. PubMed ID: 6111404
[TBL] [Abstract][Full Text] [Related]
2. Dynamics of injected somatostatin in blood of patients with hepatic failure and acromegaly.
Kastin AJ; Arimura A; Gonzalez-Barcena D; Fishback J; Schally AV; Coy DH
Peptides; 1980; 1(3):257-9. PubMed ID: 6112735
[TBL] [Abstract][Full Text] [Related]
3. Glucose homeostasis in acromegaly: effects of long-acting somatostatin analogues treatment.
Baldelli R; Battista C; Leonetti F; Ghiggi MR; Ribaudo MC; Paoloni A; D'Amico E; Ferretti E; Baratta R; Liuzzi A; Trischitta V; Tamburrano G
Clin Endocrinol (Oxf); 2003 Oct; 59(4):492-9. PubMed ID: 14510913
[TBL] [Abstract][Full Text] [Related]
4. Serum leptin levels in patients with acromegaly before and after correction of hypersomatotropism by trans-sphenoidal surgery.
Damjanović SS; Petakov MS; Raicević S; Micić D; Marinković J; Dieguez C; Casanueva FF; Popović V
J Clin Endocrinol Metab; 2000 Jan; 85(1):147-54. PubMed ID: 10634378
[TBL] [Abstract][Full Text] [Related]
5. Elevated circulating somatostatin levels in acromegaly.
Arosio M; Porretti S; Epaminonda P; Giavoli C; Gebbia C; Penati C; Beck-Peccoz P; Peracchi M
J Endocrinol Invest; 2003 Jun; 26(6):499-502. PubMed ID: 12952361
[TBL] [Abstract][Full Text] [Related]
6. Relationships between insulin-like growth factor-1 levels and growth hormone concentrations during diurnal profiles and following oral glucose in acromegaly.
Dobrashian RD; O'Halloran DJ; Hunt A; Beardwell CG; Shalet SM
Clin Endocrinol (Oxf); 1993 Jun; 38(6):589-93. PubMed ID: 8334745
[TBL] [Abstract][Full Text] [Related]
7. Dose-response study of the inhibiting effect of somatostatin on growth hormone and insulin secretion in normal subjects and acromegalic patients.
Giustina G; Peracchi M; Reschini E; Panerai E; Pinto M
Metabolism; 1975 Jul; 24(7):807-15. PubMed ID: 1138156
[TBL] [Abstract][Full Text] [Related]
8. Ghrelin test for the assessment of GH status in successfully treated patients with acromegaly.
Pekic S; Doknic M; Miljic D; Joksimovic M; Glodic J; Djurovic M; Dieguez C; Casanueva F; Popovic V
Eur J Endocrinol; 2006 May; 154(5):659-66. PubMed ID: 16645012
[TBL] [Abstract][Full Text] [Related]
9. [Changes in blood sugar, and insulin levels induced by somatostatin in normal, diabetic and acromegalic subjects].
Carmina E; Lanzara P; Janní A
Minerva Med; 1976 Apr; 67(18):1204-4-10. PubMed ID: 934480
[TBL] [Abstract][Full Text] [Related]
10. Glycemic profile in patients with acromegaly treated with somatostatin analogue.
Valea A; Carsote M; Ghervan C; Georgescu C
J Med Life; 2015; 8 Spec Issue(Spec Issue):82-6. PubMed ID: 26361517
[TBL] [Abstract][Full Text] [Related]
11. Effects of ingestion of glucose on GH and TSH secretion: evidence for stimulation of somatostatin release from the hypothalamus by acute hyperglycemia in normal man and its impairment in acromegalic patients.
Shibasaki T; Masuda A; Hotta M; Yamauchi N; Hizuka N; Takano K; Demura H; Shizume K
Life Sci; 1989; 44(6):431-8. PubMed ID: 2563893
[TBL] [Abstract][Full Text] [Related]
12. Serum thyrotropin response to combined arginine and thyrotropin-releasing hormone administration provides evidence for an altered somatostatinergic tone in acromegaly.
Merola B; Colao A; Cataldi M; Rossi E; Longobardi S; Caruso E; Lombardi G
Horm Res; 1992; 37(1-2):7-13. PubMed ID: 1356902
[TBL] [Abstract][Full Text] [Related]
13. Insulin secretion and sensitivity in acromegaly.
Jap TS; Ho LT
Clin Physiol Biochem; 1990; 8(2):64-9. PubMed ID: 2193770
[TBL] [Abstract][Full Text] [Related]
14. Serum prostate-specific antigen concentration is increased in acromegalic women.
Manetti L; Lupi I; Genovesi M; Morselli L; Grasso L; Nencetti C; Gasperi M; Bogazzi F; Bartalena L; Martino E
J Endocrinol Invest; 2004; 27(7):643-7. PubMed ID: 15505987
[TBL] [Abstract][Full Text] [Related]
15. Atrial natriuretic factor in patients with acromegaly.
Deray G; Chanson P; Maistre G; Warnet A; Eurin J; Barthelemy C; Masson F; Martinez F; Lubetzki J; Legrand JC
Eur J Clin Pharmacol; 1990; 38(5):409-13. PubMed ID: 2143136
[TBL] [Abstract][Full Text] [Related]
16. Plasma norepinephrine and epinephrine in acromegaly.
Cryer PE
J Clin Endocrinol Metab; 1975 Sep; 41(3):542-5. PubMed ID: 1159061
[TBL] [Abstract][Full Text] [Related]
17. Medical treatment of acromegaly: comorbidities and their reversibility by somatostatin analogs.
Tolis G; Angelopoulos NG; Katounda E; Rombopoulos G; Kaltzidou V; Kaltsas D; Protonotariou A; Lytras A
Neuroendocrinology; 2006; 83(3-4):249-57. PubMed ID: 17047390
[TBL] [Abstract][Full Text] [Related]
18. Glucose tolerance and plasma immunoreactive insulin levels in acromegalics before and after selective transsphenoidal surgery.
Roelfsema F; Frölich M
Clin Endocrinol (Oxf); 1985 Apr; 22(4):531-7. PubMed ID: 3886210
[TBL] [Abstract][Full Text] [Related]
19. Circulating somatostatin after food and glucose in man.
Wass JA; Penman E; Dryburgh JR; Tsiolakis D; Goldberg PL; Dawson AM; Besser GM; Rees LH
Clin Endocrinol (Oxf); 1980 Jun; 12(6):569-74. PubMed ID: 6105024
[TBL] [Abstract][Full Text] [Related]
20. Acromegaly: insensitivity of the pancreatic alpha cell to hyperglycaemia.
Seino Y; Taminato T; Goto Y; Inoue Y; Kadowaki S; Mori K; Imura H
Clin Endocrinol (Oxf); 1978 Dec; 9(6):577-81. PubMed ID: 371862
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
